Your search history is turned on.
Date: May 7, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
Microsoft Word - Sernova Q1 2024 Financial Statements (FINAL - approved March 14, 2024) NOTICE OF AMENDMENT TO THE COVER PAGE OF THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED JANUARY 31, 2024 AND 2023 OF SERNOVA CORP. The Company reports that the auditor has now completed the review of the Interim Condensed ...
Date: May 1, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
Microsoft Word - SVA Option Plan June 2 2022_ Amended 2024 - Final(40890846.5).docx SERNOVA CORP. OPTION PLAN DATED JUNE 2, 2022 AMENDED AND RESTATED AS OF MARCH 19, 2024 This Option Plan, together with the Deferred Share Unit Plan, constitute Sernovas Incentive Plan (as defined herein). - i - LEGAL_40890846.5 1. SHARE OPTION ...
Microsoft Word - DSU Plan 2024 - Final(40906659.7).docx SERNOVA CORP. DEFERRED SHARE UNIT PLAN PART 1 GENERAL PROVISIONS Establishment 1.1 Sernova Corp. (the Company) hereby establishes a deferred share unit plan known as the Deferred Share Unit Plan (this Plan). 1.2 This Plan amends, restates, supersedes and replaces the Companys original...
Microsoft Word - Sernova - Report of Voting Results - 2024 AGM(43717139.1).docx VOTING RESULTS REPORT Pursuant to Section 11.3 of National Instrument 51-102 of SERNOVA CORP. (the Company) Annual General Meeting held on April 30, 2024 10:00 a.m. Held Virtually at https://virtual-meetings.tsxtrust.com/1571 Voting Results This report on the...
Microsoft Word - SVA NR 2024 AGM RESULTS May 1 2024 Final SERNOVA ANNOUNCES AGM VOTING RESULTS LONDON, Ontario; BOSTON, Massachusetts May 1, 2024, Sernova Corp. (Sernova or the Corporation) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment of chron...
Date: April 25, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
Microsoft Word - 25April2024 Organizational Press Release Final.docx Sernova Provides Organizational Update Dr. Philip Toleikis to retire as of April 30, 2024 Cost savings from restructuring and strategic transformation anticipated to extend runway Board rebuild underway LONDON, Ontario; BOSTON, Massachusetts April 25, 2024 Sernova Corp. (TSX:SVA) (...
Date: April 22, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
Microsoft Word - Bernd M to Join Sernova Board Final (002).docx Sernova Welcomes Dr. Bernd Muehlenweg as Evotecs Nominee for its Board of Directors Dr. Daniel Mahony to step down to pursue new commitment LONDON, Ontario; BOSTON, Massachusetts April 22, 2024 Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focuse...
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
Microsoft Word - Sernova Business and Portfolio Update April 2 Final.docx Sernova Provides Positive Clinical and Platform Portfolio Update Type 1 diabetes (T1D) Cohort 2 patient data demonstrates favorable islet engraftment and long-term survival of human donor islets in the Cell Pouch First treated Cohort 1 patient in the T1D clinical trial to celebrate four y...
Date: March 28, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
NOTICE OF MEETING AND MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD VIRTUALLY AT 10:00 A.M. (PACIFIC TIME) ON TUESDAY, APRIL 30, 2024 SERNOVA CORP. Suite 114, 700 Collip Circle, London, Ontario, N6G 4X8 Telephone 1-519-858-5184 | Toll-free 1-877-299-4603 Fax...
(client logo if available) LEGAL_43369875.4 Appointee I/We, being holder(s) of common shares of SERNOVA CORP. (the Company), hereby appoint: Cynthia Pussinen, Chief Executive Officer, or, failing her, Brett Whalen, Chairman of ...